Profile | GDS4284 / 213395_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 143.515 | 44 |
GSM687648 | Patient 402 control | 132.079 | 41 |
GSM687653 | Patient 403 control | 9.85863 | 5 |
GSM687658 | Patient 404 control | 232.129 | 51 |
GSM687663 | Patient 411 control | 150.908 | 41 |
GSM687668 | Patient 422 control | 171.353 | 46 |
GSM687673 | Patient 424 control | 165.418 | 43 |
GSM687678 | Patient 425 control | 169.68 | 44 |
GSM687683 | Patient 427 control | 219.491 | 48 |
GSM687688 | Patient 428 control | 112.6 | 37 |
GSM687695 | Patient 441 control | 694.666 | 68 |
GSM687699 | Patient 443 control | 196.393 | 44 |
GSM687704 | Patient 444 control | 175.556 | 46 |
GSM687707 | Patient 448 control | 216.1 | 46 |
GSM687712 | Patient 449 control | 133.853 | 40 |
GSM687719 | Patient 450 control | 183.842 | 43 |
GSM687724 | Patient 451 control | 123.772 | 36 |
GSM687728 | Patient 452 control | 256.331 | 52 |
GSM687646 | Patient 401 treated 24h | 106.317 | 36 |
GSM687649 | Patient 402 treated 24h | 24.4285 | 16 |
GSM687665 | Patient 411 treated 24h | 91.7849 | 31 |
GSM687651 | Patient 402 treated 4 weeks | 53.0356 | 23 |
GSM687667 | Patient 411 treated 4 weeks | 150.403 | 42 |
GSM687670 | Patient 422 treated 24h | 128.756 | 38 |
GSM687671 | Patient 422 treated 4 weeks | 90.1628 | 33 |
GSM687654 | Patient 403 treated 24h | 101.852 | 37 |
GSM687675 | Patient 424 treated 24h | 190.917 | 45 |
GSM687685 | Patient 427 treated 24h | 256.056 | 52 |
GSM687656 | Patient 403 treated 4 weeks | 95.8923 | 36 |
GSM687677 | Patient 424 treated 4 weeks | 178.737 | 46 |
GSM687687 | Patient 427 treated 4 weeks | 102.334 | 37 |
GSM687692 | Patient 428 treated 4h | 38.6575 | 20 |
GSM687716 | Patient 449 treated 4h | 138.853 | 42 |
GSM687722 | Patient 450 treated 4h | 153.77 | 39 |
GSM687680 | Patient 425 treated 24h | 100.231 | 34 |
GSM687690 | Patient 428 treated 24h | 159.124 | 45 |
GSM687700 | Patient 443 treated 24h | 516.772 | 61 |
GSM687705 | Patient 444 treated 24h | 65.0911 | 28 |
GSM687714 | Patient 449 treated 24h | 202.613 | 50 |
GSM687721 | Patient 450 treated 24h | 507.968 | 62 |
GSM687682 | Patient 425 treated 4 weeks | 96.2959 | 34 |
GSM687694 | Patient 428 treated 4 weeks | 122.323 | 40 |
GSM687702 | Patient 443 treated 4 weeks | 257.17 | 51 |
GSM687718 | Patient 449 treated 4 weeks | 115.614 | 37 |
GSM687723 | Patient 450 treated 4 weeks | 227.187 | 50 |
GSM687661 | Patient 404 treated 4h | 275.625 | 53 |
GSM687710 | Patient 448 treated 4h | 187.973 | 47 |
GSM687726 | Patient 451 treated 4h | 111.986 | 33 |
GSM687730 | Patient 452 treated 4h | 1441.19 | 80 |
GSM687660 | Patient 404 treated 24h | 159.677 | 39 |
GSM687697 | Patient 441 treated 24h | 423.299 | 59 |
GSM687709 | Patient 448 treated 24h | 97.944 | 32 |
GSM687725 | Patient 451 treated 24h | 59.5925 | 22 |
GSM687729 | Patient 452 treated 24h | 522.672 | 64 |
GSM687727 | Patient 451 treated 4 weeks | 87.6718 | 28 |
GSM687731 | Patient 452 treated 4 weeks | 316.708 | 55 |